We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

119 hedge funds and large institutions have $203M invested in Arena Pharmaceuticals Inc in 2016 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 11

67% more call options, than puts

Call options by funds: $1.48M | Put options by funds: $887K

30% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 30

7% more funds holding

Funds holding: 111 → 119 (+8)

10% less capital invested

Capital invested by funds: $225M → $203M (-$22.1M)

Holders
119
Holders Change
+8
Holders Change %
+7.21%
% of All Funds
3.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
39
Reduced
30
Closed
11
Calls
$1.48M
Puts
$887K
Net Calls
+$597K
Net Calls Change
+$357K

Top Buyers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
+$18.8M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.24M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.1M
4
BFA
BlackRock Fund Advisors
California
+$1.09M
5
GC
Globeflex Capital
California
+$1.02M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$18.4M
2
State Street
State Street
Massachusetts
-$2.49M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.07M
4
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$455K
5
AIG
American International Group
New York
-$379K
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
26
Swiss National Bank
Switzerland
$660K – – –
TA
27
Teachers Advisors
New York
$626K +$27.4K +1,531 +4%
USAA
28
United Services Automobile Association
Texas
$611K -$18K -1,006 -3%
CS
29
Credit Suisse
Switzerland
$565K +$46.2K +2,585 +8%
QI
30
QS Investors
New York
$529K – – –
VEA
31
Virtus ETF Advisers
New York
$475K -$81.3K -4,550 -14%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$433K +$8.28K +463 +2%
TC
33
TFS Capital
Pennsylvania
$381K +$349K +19,510 +706%
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$378K – – –
ProShare Advisors
35
ProShare Advisors
Maryland
$361K +$2.73K +153 +0.7%
BG
36
BlackRock Group
United Kingdom
$358K -$2.97K -166 -0.8%
AG
37
Advisor Group
Arizona
$341K +$358K +20,017 New
State Board of Administration of Florida Retirement System
38
State Board of Administration of Florida Retirement System
Florida
$340K – – –
CCMH
39
Cornerstone Capital Management Holdings
New York
$339K -$6.26K -350 -2%
MLICM
40
Metropolitan Life Insurance Company (MetLife)
New York
$298K – – –
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$293K +$16.6K +930 +6%
NFA
42
Nationwide Fund Advisors
Ohio
$275K +$15.1K +843 +6%
Connor, Clark & Lunn Investment Management (CC&L)
43
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$261K – – –
AIG
44
American International Group
New York
$241K -$379K -21,205 -60%
VKH
45
Virtu KCG Holdings
New York
$233K +$151K +8,449 +163%
UBS AM
46
UBS AM
Illinois
$205K – – –
BA
47
BlackRock Advisors
Delaware
$204K +$12.5K +701 +6%
VOYA Investment Management
48
VOYA Investment Management
Georgia
$193K – – –
Jacobs Levy Equity Management
49
Jacobs Levy Equity Management
New Jersey
$178K +$186K +10,414 New
Wells Fargo
50
Wells Fargo
California
$161K -$23K -1,287 -12%
1
2
3 4 5

ARNA Hedge Fund Activity: Q2 2016 in Review

119 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2016, worth a combined $203M — down 9.8% from $225M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ARNA positions and 11 closed out — a net gain of 8 holders — while 39 added to existing stakes and 30 trimmed.

The largest buyer was Camber Capital Management, opening a new position worth an estimated $18.8M. The largest seller was RA Capital Management, exiting entirely with an estimated $18.4M sold.

  • 119 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2016, up from 111 in Q1 2016.
  • Funds reported $203M of Arena Pharmaceuticals Inc stock for Q2 2016, down 9.8% quarter-over-quarter.
  • 19 funds opened new Arena Pharmaceuticals Inc positions in Q2 2016 and 11 closed out, a net change of +8 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2016 was Camber Capital Management, an estimated $18.8M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2016 was RA Capital Management, an estimated $18.4M sold.

Based on aggregated 13F filings for Q2 2016.